Regenxbio (RGNX) Total Non-Current Liabilities (2015 - 2026)
Regenxbio's Total Non-Current Liabilities was $314.37 million in Q2 2026, down 14.3% from $366.68 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Regenxbio came in at $349.66 million, up 72.5% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $202.7 million in FY2024 (-7.3%), $218.74 million in FY2023 (-4.1%), $228.07 million in FY2022 (+5.5%) and $216.15 million in FY2021 (+38.6%).
- The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q1 2025.
- Compared with a year earlier, Total Non-Current Liabilities was higher in four of the last seven quarters, with growth averaging 34.8%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2025 (growth of 103.7%); the worst was Q3 2024 (a decline of 16.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Regenxbio | 391.13 Mn | -541.96 Mn | - | 314.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 314.37 Mn |
| Dec 31, 2025 | 349.66 Mn |
| Sep 30, 2025 | 363.10 Mn |
| Jun 30, 2025 | 366.68 Mn |
| Mar 31, 2025 | 204.93 Mn |
| Dec 31, 2024 | 202.70 Mn |
| Sep 30, 2024 | 179.07 Mn |
| Jun 30, 2024 | 176.51 Mn |
| Mar 31, 2024 | 190.36 Mn |
| Dec 31, 2023 | 212.49 Mn |
| Sep 30, 2023 | 211.40 Mn |
| Jun 30, 2023 | 203.15 Mn |
| Mar 31, 2023 | 199.33 Mn |
| Dec 31, 2022 | 219.24 Mn |
| Sep 30, 2022 | 208.22 Mn |
| Jun 30, 2022 | 200.23 Mn |
| Mar 31, 2022 | 205.51 Mn |
| Dec 31, 2021 | 215.40 Mn |
| Sep 30, 2021 | 194.18 Mn |
| Jun 30, 2021 | 177.57 Mn |
API Access
Regenxbio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();